- Fee assured
- Awaiting verification
- Inflammatory bowel disease
Lead Gastroenterologist and physician in Digestive diseases and Nutrition Unit. Research Lead in Inflammatory Bowel Disease and Irritable bowel syndrome. National lead in drug therapy trial in Ulcerative colitis. Wrote Guideline for Biologics usages in Inflammatory Bowel Disease.
Areas of interest
Dyspepsia, swallowing difficulties, IBS and Fatty liver.
Dr Hoque is the lead Gastroenterologist & physician in Digestive Disease and Nutrition at Whipps Cross University Hospital
and Principal Investigator for Basic Science and Clinical research, currently running several novel
therapeutic drug trials in Inflammatory bowel Disease (Ulcerative colitis and Crohn’s Disease) and
Dr Hoque is highly experienced and advanced level Endoscopist (Endoscopic Ultrasound and Laser
therapy) as well as a colonoscopy trainer,.
Current NHS consultant posts held
Consultant Gastroenterologist and Physician at Barts Health NHS Trust, Whipps Cross University Hospital
Inflammatory Bowel Disease (ulcerative Colitis & Crohn's Disease) and Irritable Bowel Syndrome.
Golf, travelling and cooking.
Awarded Best Research paper By the American College of Gastroenterology, 1999.
Received awards for the Best Research student by the Council of Vice-Principals of the UK Universities.
44 Scientific Publications and one book chapter.
Courses offered to GPs
"IBS and IBD: similar Beginning but different Ending"
"When to refer for GI investigations?"
"What to do when colitis flare up"
"How to mage difficult IBS patent"
- FRCP, FRCPE, Royal College Of Physicians UK 2012
- PhD University of Edinburgh 2000
Reference number 5168320
Professional bodies (positions held - last 3 yrs)
- FACG American College of Gastroenterology 2000
Details of entry to specialist register
- Gastroenterology, 2009
- Holly House Hospital, IG9 5HX
- 13:00 - 06:30
- 07780 351793
- Spire Roding Hospital, IG4 5PZ
- 06:00 - 20:00
- 07780 351793
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details